MAPT and Alzheimer disease: Higher BMI in mid-life is also associated with neuropathological hallmarks of AD, i.e., greater β-amyloid (Aβ) and tau deposition (Mrak, 2009; Chuang et al., 2016; Merrill et al., 2016).